These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3617752)

  • 21. [Effect of body position on the ability to initiate paroxysmal supraventricular reentry tachycardias and on the conduction system properties of the reentry circuit].
    Dannberg G; Volkmann H; Kühnert H
    Z Gesamte Inn Med; 1987 Jun; 42(11):289-94. PubMed ID: 3660882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative effectiveness of finoptin and phosphobion in treating attacks of supraventricular tachycardia].
    Lukoshiavichiute AI; Gedrimene DA
    Kardiologiia; 1989 Apr; 29(4):64-9. PubMed ID: 2666710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [First experiences with the effect of low-energy electric impulse on the atrioventricular junction in various types of paroxysmal supraventricular tachycardia].
    Gimrikh EO; Chekhov AM; Popov SV; Rezanov BR; Stepanov AS; Gushchin IB; Cherniavskiĭ AM; Pekarskiĭ VV
    Kardiologiia; 1989 Jul; 29(7):40-3. PubMed ID: 2811036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiological mechanisms of the effect of allapinin in patients with paroxysmal supraventricular tachycardia].
    Sokolov SF; Golitsyn SP; Manakhov VI; Zagraĭ AA; Bankuzov VA; Smetnev AS
    Kardiologiia; 1991 Mar; 31(3):38-42. PubMed ID: 1875595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current treatment options for paroxysmal supraventricular tachycardia.
    Mannino MM; Mehta D; Gomes JA
    Am Heart J; 1994 Feb; 127(2):475-80. PubMed ID: 8296727
    [No Abstract]   [Full Text] [Related]  

  • 27. [Criteria for a pathogenetic approach to antiarrhythmic therapy in paroxysmal supraventricular reciprocal tachycardia].
    Chireĭkin LV; Shubik IuV; Tiunin MI
    Kardiologiia; 1990 Jun; 30(6):55-9. PubMed ID: 2214533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adenosine triphosphate and supraventricular tachycardia].
    Pella J
    Vnitr Lek; 1994 Nov; 40(11):702-6. PubMed ID: 7810092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
    Chiou CW; Chen SA; Kung MH; Chang MS; Prystowsky EN
    Circulation; 2003 May; 107(20):2583-8. PubMed ID: 12743004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine-induced non-sustained polymorphic ventricular tachycardia.
    Romer M; Candinas R
    Eur Heart J; 1994 Feb; 15(2):281-2. PubMed ID: 8005132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tale of two post pacing intervals.
    Veenhuyzen GD; Stuglin C; Zimola KG; Mitchell LB
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):687-9. PubMed ID: 16836725
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
    Schläpfer J; Fromer M; Kappenberger L
    Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel pacing manoeuvre to diagnose atrial tachycardia.
    Sarkozy A; Richter S; Chierchia GB; De Asmundis C; Seferlis C; Brugada P; Kaufman L; Buyl R; Dorian P; Mangat I
    Europace; 2008 Apr; 10(4):459-66. PubMed ID: 18299309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple atrioventricular nodal pathways can be masked.
    Yamashita T; Murakawa Y; Ajiki K; Omata M
    Am J Cardiol; 1996 Jun; 77(15):1365-7. PubMed ID: 8677882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and electrophysiologic action of amiodarone in controlling attacks of supraventricular paroxysmal tachycardia].
    Lukoshiavichiute AI; Gedrimene DA
    Kardiologiia; 1989 Jul; 29(7):11-4. PubMed ID: 2811028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protective electrophysiological effects of somatostatin in patients with paroxysmal atrioventricular reciprocal tachycardias].
    Kanorskií SG; Osadchií OE; Skibitskií VV; Pokrovskií VM
    Patol Fiziol Eksp Ter; 2002; (2):18-9. PubMed ID: 12152423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical course of paroxysmal reciprocal atrioventricular tachycardias under long-term prospective observation].
    Grosu AA; Shevchenko NM
    Ter Arkh; 1992; 64(12):80-3. PubMed ID: 1292141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.